Document is current
Any future updates will be listed below
-
Authors
McAvoy, Malia https://orcid.org/0000-0002-9998-4737
Bui, Ai-Tram N. https://orcid.org/0000-0003-0133-7935
Hansen, Christopher https://orcid.org/0000-0002-6640-2745
Plana, Deborah https://orcid.org/0000-0002-4218-1693
Said, Jordan T. https://orcid.org/0000-0002-0357-6916
Yu, Zizi https://orcid.org/0000-0001-8566-0777
Yang, Helen https://orcid.org/0000-0002-9455-5300
Freake, Jacob https://orcid.org/0000-0002-5198-835X
Van, Christopher https://orcid.org/0000-0003-3262-964X
Krikorian, David
Cramer, Avilash https://orcid.org/0000-0003-0014-8921
Smith, Leanne
Jiang, Liwei https://orcid.org/0000-0002-1863-6803
Lee, Karen J. https://orcid.org/0000-0003-4255-8355
Li, Sara J.
Beller, Brandon
Huggins, Kimberley
Short, Michael P. https://orcid.org/0000-0002-9216-2482
Yu, Sherry H. https://orcid.org/0000-0002-1432-9128
Mostaghimi, Arash https://orcid.org/0000-0002-6084-5617
Sorger, Peter K. https://orcid.org/0000-0002-3364-1838
LeBoeuf, Nicole R. https://orcid.org/0000-0002-8264-834X
-
Funding
Funding for this research was provided by:
Harvard MIT Center for Regulatory Sciences (Harvard MIT Center for Regulatory Sciences)
National Cancer Institute (U54-CA225088, U54-CA225088, U54-CA225088)
National Institute of General Medical Sciences (T32-GM007753)
- License Information
-
More Information
Article History
Received: 23 July 2020
Accepted: 9 May 2021
First Online: 7 June 2021
Declarations
:
: The Partners Healthcare Institutional Review Board (Office for Human Research Protections registration numbers IRB00012706 and IRB00012707) approved this study (protocol #2020P001209). Consent was not written; instead, all volunteers provided verbal informed consent. Verbal consent was obtained from study subjects due to the COVID-19 pandemic to minimize contact transfer of objects between participants. The Partners Healthcare Institutional Review Board approved this procedure.
: Consent for publication has been obtained from the study participants. Written informed consent for publication was obtained from the study participants pictured in Fig. and Additional Material .
: A Mostaghimi is a consultant or has received honoraria from Pfizer, 3Derm, and hims and has equity in Lucid Dermatology and hims. He is an associate editor for JAMA Dermatology. Mostaghimi declares that none of these relationships are directly or indirectly related to the content of this manuscript.PK Sorger is a member of the SAB or Board of Directors of Applied Biomath, Glencoe Software and RareCyte Inc and has equity in these companies. In the last five years the Sorger lab has received research funding from Novartis and Merck. Sorger declares that none of these relationships are directly or indirectly related to the content of this manuscript.NR LeBoeuf is a consultant for or has received honoraria from the following companies: Seattle Genetics, Sanofi, Bayer, Seattle Genetics, Sanofi, Silverback and Synox Therapeutics outside the submitted work.
